SHARON DICKMAN: Open Payments
NPI 1043555691 · LEXINGTON, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$801 in 41 payments from 13 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $801
Food & beverage: $801
| Company | Payments | Amount |
|---|---|---|
| CSL Behring | 19 | $272 |
| AstraZeneca Pharmaceuticals LP | 4 | $156 |
| Novartis Pharmaceuticals Corporation | 4 | $89 |
| GENZYME CORPORATION | 3 | $75 |
| ARS Pharmaceuticals Operations, Inc. | 2 | $38 |
| GlaxoSmithKline, LLC. | 2 | $36 |
| Cycle Pharmaceuticals Inc | 1 | $25 |
| Genentech USA, Inc. | 1 | $23 |
| Ionis Pharmaceuticals, Inc. | 1 | $22 |
| Amgen Inc. | 1 | $18 |
Products named: TEZSPIRE, Andembry, Hizentra, Haegarda, DUPIXENT, NEFFY, Sajazir, Xolair.
Industry payments across KY — which companies pay providers there.
